⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for recurrent islet cell carcinoma

Every month we try and update this database with for recurrent islet cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine TumorsNCT00075439
Gastrinoma
Glucagonoma
Insulinoma
Metastatic Gast...
Pancreatic Poly...
Recurrent Gastr...
Recurrent Islet...
Somatostatinoma
WDHA Syndrome
gefitinib
laboratory biom...
18 Years - National Cancer Institute (NCI)
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerNCT00005842
Cancer
trastuzumab
tipifarnib
18 Years - National Cancer Institute (NCI)
Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By SurgeryNCT01465659
Pancreatic Alph...
Pancreatic Beta...
Pancreatic Delt...
Pancreatic G-ce...
Recurrent Islet...
temozolomide
pazopanib hydro...
18 Years - Northwestern University
Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine TumorsNCT00602082
Gastrointestina...
Islet Cell Tumo...
capecitabine
cisplatin
streptozocin
DNA analysis
RNA analysis
protein analysi...
proteomic profi...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the PeritoneumNCT00005860
Cancer
floxuridine
leucovorin calc...
oxaliplatin
18 Years - National Cancer Institute (NCI)
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic DisordersNCT00830557
Islet Cell Tumo...
Pancreatic Canc...
Pancreatic Dise...
medical chart r...
survey administ...
biospecimen col...
18 Years - 120 YearsMayo Clinic
Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By SurgeryNCT00416767
Gastrointestina...
Islet Cell Tumo...
Neoplastic Synd...
fluorouracil
irinotecan hydr...
leucovorin calc...
18 Years - 80 YearsFederation Francophone de Cancerologie Digestive
Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine TumorsNCT00227617
Gastrointestina...
Islet Cell Tumo...
Lung Cancer
Neoplastic Synd...
Neuroendocrine ...
bevacizumab
5-fluorouracil
leucovorin
oxaliplatin
18 Years - University of California, San Francisco
Thalidomide in Treating Patients With Metastatic Neuroendocrine TumorsNCT00027638
Gastrointestina...
Islet Cell Tumo...
Lung Cancer
Neoplastic Synd...
thalidomide
- Memorial Sloan Kettering Cancer Center
Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine TumorsNCT00227773
Gastrointestina...
Islet Cell Carc...
octreotide acet...
vatalanib
anti-cytokine t...
antiangiogenesi...
biological ther...
endocrine thera...
enzyme inhibito...
growth factor a...
hormone therapy
protein tyrosin...
somatostatin an...
18 Years - 120 YearsEastern Cooperative Oncology Group
Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine TumorsNCT02259725
Gastrinoma
Glucagonoma
Insulinoma
Metastatic Gast...
Pancreatic Poly...
Pulmonary Carci...
Recurrent Gastr...
Recurrent Islet...
Somatostatinoma
regorafenib
laboratory biom...
18 Years - University of Southern California
Thalidomide in Treating Patients With Metastatic Neuroendocrine TumorsNCT00027638
Gastrointestina...
Islet Cell Tumo...
Lung Cancer
Neoplastic Synd...
thalidomide
- Memorial Sloan Kettering Cancer Center
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsNCT01155258
Extensive Stage...
Hereditary Para...
Male Breast Can...
Malignant Parag...
Metastatic Gast...
Metastatic Pheo...
Pancreatic Poly...
Recurrent Breas...
Recurrent Cervi...
Recurrent Endom...
Recurrent Gastr...
Recurrent Islet...
Recurrent Neuro...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pheoc...
Recurrent Prost...
Recurrent Renal...
Recurrent Small...
Recurrent Uteri...
Regional Gastro...
Regional Pheoch...
Stage III Cervi...
Stage III Endom...
Stage III Neuro...
Stage III Ovari...
Stage III Ovari...
Stage III Prost...
Stage III Renal...
Stage III Uteri...
Stage IIIA Brea...
Stage IIIA Non-...
Stage IIIB Brea...
Stage IIIB Non-...
Stage IIIC Brea...
Stage IV Breast...
Stage IV Endome...
Stage IV Neuroe...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Prosta...
Stage IV Renal ...
Stage IV Uterin...
Stage IVA Cervi...
Stage IVB Cervi...
Thyroid Gland M...
temsirolimus
vinorelbine dit...
18 Years - University of Southern California
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerNCT00005842
Cancer
trastuzumab
tipifarnib
18 Years - National Cancer Institute (NCI)
Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney CancerNCT02273752
Estrogen Recept...
Gastrinoma
Glucagonoma
HER2-negative B...
Insulinoma
Mucositis
Oral Complicati...
Pancreatic Poly...
Progesterone Re...
Recurrent Breas...
Recurrent Islet...
Recurrent Renal...
Somatostatinoma
Stage III Renal...
Stage IIIA Brea...
Stage IIIB Brea...
Stage IIIC Brea...
Stage IV Breast...
Stage IV Renal ...
Everolimus
18 Years - Emory University
Temsirolimus in Treating Patients With Metastatic Neuroendocrine CarcinomaNCT00093782
Metastatic Gast...
Pulmonary Carci...
Recurrent Gastr...
Recurrent Islet...
temsirolimus
laboratory biom...
18 Years - National Cancer Institute (NCI)
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsNCT01155258
Extensive Stage...
Hereditary Para...
Male Breast Can...
Malignant Parag...
Metastatic Gast...
Metastatic Pheo...
Pancreatic Poly...
Recurrent Breas...
Recurrent Cervi...
Recurrent Endom...
Recurrent Gastr...
Recurrent Islet...
Recurrent Neuro...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pheoc...
Recurrent Prost...
Recurrent Renal...
Recurrent Small...
Recurrent Uteri...
Regional Gastro...
Regional Pheoch...
Stage III Cervi...
Stage III Endom...
Stage III Neuro...
Stage III Ovari...
Stage III Ovari...
Stage III Prost...
Stage III Renal...
Stage III Uteri...
Stage IIIA Brea...
Stage IIIA Non-...
Stage IIIB Brea...
Stage IIIB Non-...
Stage IIIC Brea...
Stage IV Breast...
Stage IV Endome...
Stage IV Neuroe...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Prosta...
Stage IV Renal ...
Stage IV Uterin...
Stage IVA Cervi...
Stage IVB Cervi...
Thyroid Gland M...
temsirolimus
vinorelbine dit...
18 Years - University of Southern California
Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine TumorsNCT00075439
Gastrinoma
Glucagonoma
Insulinoma
Metastatic Gast...
Pancreatic Poly...
Recurrent Gastr...
Recurrent Islet...
Somatostatinoma
WDHA Syndrome
gefitinib
laboratory biom...
18 Years - National Cancer Institute (NCI)
Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine TumorsNCT00466856
Head and Neck C...
Islet Cell Tumo...
Metastatic Canc...
Pheochromocytom...
octreotide acet...
yttrium Y 90 re...
18 Years - Vanderbilt-Ingram Cancer Center
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic DisordersNCT00830557
Islet Cell Tumo...
Pancreatic Canc...
Pancreatic Dise...
medical chart r...
survey administ...
biospecimen col...
18 Years - 120 YearsMayo Clinic
Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine TumorsNCT02108782
Gastrinoma
Glucagonoma
Insulinoma
Pancreatic Poly...
Recurrent Islet...
Somatostatinoma
dovitinib lacta...
pharmacological...
laboratory biom...
18 Years - Academic and Community Cancer Research United
Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine TumorsNCT00131911
Gastrinoma
Glucagonoma
Insulinoma
Metastatic Gast...
Neuroendocrine ...
Pancreatic Poly...
Recurrent Gastr...
Recurrent Islet...
Somatostatinoma
WDHA Syndrome
sorafenib tosyl...
18 Years - National Cancer Institute (NCI)
Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By SurgeryNCT00416767
Gastrointestina...
Islet Cell Tumo...
Neoplastic Synd...
fluorouracil
irinotecan hydr...
leucovorin calc...
18 Years - 80 YearsFederation Francophone de Cancerologie Digestive
AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine TumorsNCT00427349
Gastrointestina...
Islet Cell Tumo...
Neoplastic Synd...
AMG 706
octreotide
18 Years - Eastern Cooperative Oncology Group
AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine TumorsNCT00427349
Gastrointestina...
Islet Cell Tumo...
Neoplastic Synd...
AMG 706
octreotide
18 Years - Eastern Cooperative Oncology Group
Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine TumorsNCT00227773
Gastrointestina...
Islet Cell Carc...
octreotide acet...
vatalanib
anti-cytokine t...
antiangiogenesi...
biological ther...
endocrine thera...
enzyme inhibito...
growth factor a...
hormone therapy
protein tyrosin...
somatostatin an...
18 Years - 120 YearsEastern Cooperative Oncology Group
Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine TumorsNCT02259725
Gastrinoma
Glucagonoma
Insulinoma
Metastatic Gast...
Pancreatic Poly...
Pulmonary Carci...
Recurrent Gastr...
Recurrent Islet...
Somatostatinoma
regorafenib
laboratory biom...
18 Years - University of Southern California
Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerNCT00006368
Brain and Centr...
Breast Cancer
Gastrointestina...
Islet Cell Tumo...
Lung Cancer
Lymphoma
Melanoma (Skin)
Neoplastic Synd...
yttrium Y 90-ed...
18 Years - Novartis
Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine TumorsNCT00084461
Gastrinoma
Glucagonoma
Insulinoma
Metastatic Gast...
Pancreatic Poly...
Pulmonary Carci...
Recurrent Gastr...
Recurrent Islet...
Regional Gastro...
Somatostatinoma
romidepsin
laboratory biom...
18 Years - National Cancer Institute (NCI)
Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With SurgeryNCT02031536
Gastrinoma
Glucagonoma
Insulinoma
Liver Metastase...
Pancreatic Poly...
Recurrent Islet...
Somatostatinoma
everolimus
placebo
18 Years - Eastern Cooperative Oncology Group
Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerNCT00096083
Cancer
isolated perfus...
melphalan
16 Years - Delcath Systems Inc.
Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine TumorsNCT00084461
Gastrinoma
Glucagonoma
Insulinoma
Metastatic Gast...
Pancreatic Poly...
Pulmonary Carci...
Recurrent Gastr...
Recurrent Islet...
Regional Gastro...
Somatostatinoma
romidepsin
laboratory biom...
18 Years - National Cancer Institute (NCI)
Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine TumorsNCT01525082
Gastrinoma
Glucagonoma
Insulinoma
Pancreatic Poly...
Recurrent Islet...
Recurrent Pancr...
Somatostatinoma
Stage III Pancr...
Stage IV Pancre...
Capecitabine
Temozolomide
Bevacizumab
18 Years - Stanford University
Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine TumorsNCT01824875
Gastrinoma
Glucagonoma
Insulinoma
Islet Cell Carc...
Pancreatic Poly...
Recurrent Islet...
Somatostatinoma
temozolomide
capecitabine
18 Years - Eastern Cooperative Oncology Group
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: